A

AN2 Therapeutics
D

ANTX

5.02500
USD
-0.37
(-6.77%)
مغلق
حجم التداول
19,743
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
180,981,209
المقالات
المزيد

العنوان: AN2 Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.